When supply chain folks think about anti-counterfeiting in the pharmaceutical supply chain, we naturally think about bar codes and RFID. Those technologies have a role to play, but the requirements go far beyond the simple tracking that occurs in many other supply chains.
My colleagues Janice Abel and John Blanchard have written an ARC Insight (available to ARC clients only) on preventing counterfeiting in the pharmaceutical industry that… Continue reading
Last month, antidepressants worth $75 million were stolen from an Eli Lilly warehouse in Enfield, Connecticut. According to an article in the Spokesman-Review, “the thieves cut a hole in the roof, lowered themselves into the building on ropes, disabled the alarm system and stole enough drugs to fill a tractor-trailer. The stolen pharmaceuticals included the best-selling antidepressants Prozac and Cymbalta.”
Last August, a GlaxoSmithKline warehouse was victimized
My ARC colleague Janice Abel told me a story recently that is making me question the safety and efficacy of prescription drugs purchased online.
Janice was visiting her stepfather who had been away from home for a long weekend. When he returned and went out to the mailbox, on a hot summer day in the 90s, he saw that his diabetes medicine had arrived, but the ice pack in… Continue reading
Once upon a time there was a global, medical products company that was very unhappy with the way it was treating its customers in Asia. The company’s main customers are hospitals that use its products in emergency room surgeries. Not surprisingly, its customers wanted a high level of product availability. But this was a problem because the company’s factories are primarily located in North America and Europe, even though Asia… Continue reading
“The arrival of swine flu in the United States exposed gaps in the supply chain that delivers medication, masks, and even testing swabs to hospitals and doctors’ offices – shortcomings that could prove vastly more worrisome if a deadlier strain returns in the fall, officials say.”
So begins an article published this week in The Boston Globe by Stephen Smith. Although the U.S. health system responded very well… Continue reading
New from Sponsor Blogs
Recent Comments